Marcus R. Anderson, M.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2007 | The University of Texas Health Science Center at Houston Medical School, Houston, Texas, US, M.D |
| 2003 | Houston Baptist University, Houston, Texas, US, BS in Chemistry, Biology, Computer Information Science Management |
Postgraduate Training
| 2012-2013 | Clinical Fellowship, Abdominal Imaging, M.D. Anderson Cancer Center, Houston, Texas |
| 2008-2012 | Clinical Residency, Radiology, Saint Louis University, St. Louis, Missouri |
| 2006-2007 | Clinical Internship, Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas |
Board Certifications
| 2012 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
Organizer of UT Radiology Resident lectures given by MDA Abdominal imaging faculty, Department of Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Organizing and assimilating evaluations of rotating radiology residents in MRI, US, and CT. Submit monthly reviews to the UT and Baylor program directors, Department of Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Other Appointments/Responsibilities
Body Imaging Radiologist, Houston Northwest Radiology Association, Houston, TX, 2020 - 2021
Body Imaging Radiologist, Associates of Radiology of Texas, Houston, TX, 2013 - 2020
Institutional Committee Activities
Member, Medical Records Committee, 2024 - Present
Honors & Awards
| 2022 | Awesome Job Award, MDA |
| 2011 - 2012 | Chief Resident, Saint Louis University |
| 2010 - 2011 | Junior Chief Resident, Saint Louis University |
| 2004 | NIH Summer Research Scholar,, University of Texas Health Science Center at Houston Medical School |
| 2004 | Outstanding Academic Achievement in Pathology, University of Texas Health Science Center at Houston Medical School |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Ahmad M, Anderson MR, Jensen CT. Low pitch significantly reduces helical artifacts in abdominal CT. Eur J Radiol 166, 2023. e-Pub 2023. PMID: 37481832.
- Ahmad M, Liu X, Morani AC, Ganeshan D, Anderson MR, Samei E, Jensen CT. Oncology-specific radiation dose and image noise reference levels in adult abdominal-pelvic CT. Clin Imaging 93:52-59, 2023. e-Pub 2023. PMID: 36375364.
- Dai H, Li R, Wheeler T, Ozen M, Ittmann M, Anderson M, Wang Y, Rowley D, Younes M, Ayala GE. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol 38(2):299-307, 2007. e-Pub 2007. PMID: 17097719.
Other Articles
- Elsherif SB, Anderson M, Chaudhry AA, Kumar SP, Gopireddy DR, Lall C, Bhosale PR Response criteria for immunotherapy and the radiologic patterns of immune-related adverse events. Eur J Radiol 146:110062, 2022. PMID: 34890935.
Abstracts
- Stephen B, Kwiatkowski E, Anderson MR, Derbala MH, Salih I, Castillo L, Yang Y, Gurses S, Lim JT, Klekers AR, Le H, Kang L, Xu M, Dumbrava EE, Fu S, Piha-Paul SA, Ahnert JR, Tsimberidou AM, Yap TA, Yuan Y, Hong DS, Meric-Bernstam F, Bhosale PR, Naing A. Impact of liver metastases and systemic biomarkers on immunotherapy response and survival outcomes in patients with solid tumors. American Association of Cancer Research - Immuno-Oncology, 2025.
- Stephen B, Anderson MR, Kwiatkowski E, Yang Y, Lim JT, Klekers AR, Dumbrava EE, Fu S, Karp DD, Piha-Paul SA, Ahnert JR, Tsimberidou AM, Yap TA, Yuan Y, Hong DS, Meric-Bernstam F, Bhosale PR, Naing A. Impact of liver metastases on immunotherapy in patients with solid tumors, 2024.
- Soo Park PY, Gao M, Anderson M, Diagnostic EA, Bathala TK. Diagnostic performance of multiparametric MRI in the evaluation of radio-recurrent prostate cancer using the Prostate Imaging for Recurrence Reporting guidelines (PI-RR) and histopathologic correlation. Society of Abdominal Radiology, 2022. e-Pub 2022.
- Edmund Yang, Anderson MR. Initial human experience using hydrogel polymers for tracheal occlusion in liver up congenital diaphragmatic hernia. International Fetal Medicine and Surgery Society Conference.
- Anderson MR, Ganeshan D, Iyer RB. Common and Uncommon Complications following Esophagectomy for Esophageal Cancer- Review of clinical experience over 450 patients. American Roentgen Ray Society.
Selected Presentations & Talks
Local Presentations
- 2008. Positron Emission Tomography (PET) imaging and Pediatrics; a retrospective study of possible diagnostic applications. Poster. Positron Emission Tomography (PET) imaging and Pediatrics; a retrospective study of possible diagnostic applications. Houston, TX, US.
National Presentations
- 2013. Common and Uncommon Complications following Esophagectomy for Esophageal Cancer- Review of clinical experience over 450 patients. Poster. American Roentgen Ray Society Annual Meeting 2013. Washington DC, US.
Formal Peers
- 2025. Beyond the Reading Room: Hobbies, Hacks, and How We Flourish. Houston, Texas, US.
- 2022. Introduction to Radiology and the basics of RECITST criteria. Houston, Texas, US.
- 2013. Basics of penile MRI. Houston, Texas, US.
Grant & Contract Support
| Date: | 2024 - Present |
| Title: | Evaluation of efficacy and immune-related adverse events and patient reported symptoms associated with immunotherapies: MD Anderson Cancer Center efforts for advanced mechanistic, clinical, and translational science |
| Funding Source: | MD Anderson Cancer Center, NIH |
| Role: | Co-I |
| ID: | PA15-0315 |
| Date: | 2024 - Present |
| Title: | PRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma |
| Funding Source: | Unkown |
| Role: | Co-I |
| ID: | IRB #:2022-0330 |
| Date: | 2024 - Present |
| Title: | An open-label, multicenter phase 1/2 study to evaluate the safety and efficacy of AB-2100 in patients with recurrent advanced or metastatic clear-cell renal cell carcinoma (ccRCC) |
| Funding Source: | ArsenalBio |
| Role: | Co-I |
| ID: | Protocol 2023-1053, NCT06245915 |
Patient Reviews
CV information above last modified June 11, 2025